Berkeley, CA, United States of America

Pierre F Indermuhle

USPTO Granted Patents = 38 

 

Average Co-Inventor Count = 4.2

ph-index = 18

Forward Citations = 821(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
38 patents (USPTO):

Title: Exploring the Innovations of Inventor Pierre F Indermuhle

Introduction: Pierre F Indermuhle, a distinguished inventor based in Berkeley, CA, has made significant contributions to the field of biomolecule retention and polynucleotide synthesis with a remarkable portfolio of 32 patents.

Latest Patents:

1. Systems and methods for biomolecule retention: Pierre's recent patent focuses on the development of compositions, systems, and methods for the display of analytes such as biomolecules. These innovative systems enable the formation of arrays of analytes for use in various assays and methods.

2. Heated nanowells for polynucleotide synthesis: Another groundbreaking patent by Pierre involves the synthesis of modified RNA in the 3' to 5' direction. His approach utilizing reverse RNA monomer phosphoramidites has revolutionized oligonucleotide synthesis, allowing for clean synthesis and the introduction of diverse modifications at the 3' end.

Career Highlights: Pierre F Indermuhle has worked with reputable companies like Twist Bioscience Corporation, where he has demonstrated his expertise in the fields of biomolecule retention and polynucleotide synthesis. His innovative solutions have paved the way for advancements in biotechnology and pharmaceutical research.

Collaborations: Throughout his career, Pierre has collaborated with accomplished professionals in the field, including notable coworkers such as Bill James Peck and Andres Fernandez. These collaborations have fostered a dynamic environment for innovation and knowledge exchange.

Conclusion: Inventor Pierre F Indermuhle's relentless pursuit of excellence in biomolecule retention and polynucleotide synthesis has significantly impacted the scientific community. His inventive solutions continue to drive progress in biotechnology and hold promise for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…